Antifracture Efficacy of 5- or 10-Yearly Zoledronate in Women Aged 50 to 60 Years: Secondary Analyses of a Randomized Trial - Poll - MDSpire

Antifracture Efficacy of 5- or 10-Yearly Zoledronate in Women Aged 50 to 60 Years: Secondary Analyses of a Randomized Trial

  • By

  • Mark J Bolland

  • Zaynah Nisa

  • Anna Mellar

  • Chiara Gasteiger

  • Veronica Pinel

  • Borislav Mihov

  • Sonja Bastin

  • Andrew Grey

  • Ian R Reid

  • Greg Gamble

  • Anne Horne

  • October 18, 2025

  • 0 min

Share

Original Source(s)

Antifracture Efficacy of 5- or 10-Yearly Zoledronate in Women Aged 50 to 60 Years: Secondary Analyses of a Randomized Trial

  • by Mark J Bolland, Zaynah Nisa, Anna Mellar, Chiara Gasteiger, Veronica Pinel, Borislav Mihov, Sonja Bastin, Andrew Grey, Ian R Reid, Greg Gamble, Anne Horne

  • October 18, 2025

Related Content

The role of gut microbiota in osteoporosis: underlying mechanisms, clinical associations, and emerging biomaterials

Lower odds of prevalent vertebral fractures with b/tsDMARD use among rheumatoid arthritis patients in clinical remission: a retrospective observational study

Phosphaturic mesenchymal tumor in the temporalis muscle causing tumor-induced osteomalacia: a case report and literature review